by MM360 Staff | May 26, 2025 | Myeloma News
Source: Pharmacy Times articles A panelist discusses recent advancements in the respiratory syncytial virus (RSV) vaccine space, including the approval of Arexvy and Abrysvo for older adults and pregnant individuals, the development of promising mRNA and protein...
by MM360 Staff | May 26, 2025 | Myeloma News
Source: Pharmacy Times articles A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring...
by MM360 Staff | May 24, 2025 | Myeloma News
Source: Pharmacy Times articles Christian John Lillis reflects on key insights from the 2025 Peggy Lillis Foundation C diff Summit, highlighting the critical role of pharmacists in infectious disease care, persistent challenges in patient outcomes, and the need for...
by MM360 Staff | May 24, 2025 | Myeloma News
Source: Pharmacy Times articles Market access offers pharmacists a dynamic career path. Read More
by MM360 Staff | May 24, 2025 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | May 23, 2025 | Myeloma News
Source: Pharmacy Times articles Physical activity significantly enhanced quality of life and reduced fatigue and depression in patients with newly diagnosed multiple myeloma. Read More
